U.S. Markets closed

Cempra (CEMP) Falls: Stock Plunges 12.2%

Zacks Equity Research

Cempra, Inc. (CEMP) saw a big move last session, as the company’s shares fell over 12% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading within the volatile price range of $11.2 to $13.7 in the past one-month time frame.

This pharmaceutical company has seen a flat track record when it comes to current year estimate revisions, as there has been no revision on either side over the past few weeks. The consensus for loss hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch of this firm in the near future, and especially on earnings estimates following the recent slump.

CEMP currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the Med –Drugs industry include Lannett Company, Inc. (LCI), Auxilium Pharmaceuticals Inc. (AUXL) and Shire plc (SHPG). All three carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


CEMPRA INC (CEMP): Free Stock Analysis Report

SHIRE PLC ADS (SHPG): Free Stock Analysis Report

LANNETT COMP (LCI): Free Stock Analysis Report


Zacks Investment Research